Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 30, 2016
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)R de Las Peñas, A Blasco, J De Castro, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 2, 2021
SEOM clinical guideline for the management of cutaneous melanoma (2020)M Majem, J L Manzano, I Marquez-Rodas, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2020
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)M Majem, E García-Martínez, M Martinez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 27, 2007
The oncology acute toxicity unit (OATU): an outpatient facility for improving the management of chemotherapy toxicityM Majem, M Galán, F J Pérez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 30, 2017
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 databaseJ Remon, D Isla, P Garrido, et al.
ESMO Open|February 8, 2021
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM)E Elez, F Ayala, E Felip, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2023
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trialJ Remon, B Besse, S Ponce Aix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trialA Molassiotis, K Jordan, M Karthaus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2010
First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On studyM L García de Paredes, F Del Moral González, P Martínez Del Prado, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 26, 2016
A consensus statement on the gender perspective in lung cancerD Isla, M Majem, N Viñolas, et al.
Pageof 4